Advertisements


Acer Therapeutics: Multiple Aces Up Its Sleeve

Acer Therapeutics: Multiple Aces Up Its Sleeve.....»»

Category: topSource: seekingalphaFeb 11th, 2019

FDA Delays Selinexor Approval By 3 Months — So Why Is Karyopharm Ripping Higher?

Karyopharm Therapeutics Inc (NASDAQ: KPTI) shares, which suffered a setback in late February following the release of the FDA's briefing document and panel vote on its multiple myeloma treatment c Latest Ratings for KPTI.....»»

Category: blogSource: benzingaMar 15th, 2019

Acer Therapeutics Becomes Oversold (ACER)

Dividend Channel.....»»

Category: topSource: redinewsMar 11th, 2019

Y-mAbs Therapeutics: Impressive Data In Multiple Oncology Indications, Regulatory Submissions Loom

Y-mAbs Therapeutics: Impressive Data In Multiple Oncology Indications, Regulatory Submissions Loom.....»»

Category: topSource: seekingalphaMar 10th, 2019

Aquestive Therapeutics: Specialty Pharma Company With Multiple Value Drivers

Aquestive Therapeutics: Specialty Pharma Company With Multiple Value Drivers.....»»

Category: topSource: seekingalphaFeb 28th, 2019

Karyopharm Shares Nosedive On Tough FDA Briefing For Multiple Myeloma Drug

Karyopharm Therapeutics Inc (NASDAQ: KPTI) shares were nosediving on roughly 11 times their average volume Friday following the release of the FDA briefing document read more.....»»

Category: blogSource: benzingaFeb 22nd, 2019

venBio Select Advisor LLC Buys Loxo Oncology Inc, Sarepta Therapeutics Inc, Amarin Corp PLC, ...

Related Stocks: SRPT, AMRN, ZGNX, GBT, LOXO, PTI, MDGL, PTCT, ACER, ECYT, PB,.....»»

Category: smallbizSource: nytFeb 21st, 2019

Acer Therapeutics reinstated with an Outperform at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 15th, 2019

Acer Therapeutics management to meet with Needham

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 31st, 2019

Sage Therapeutics Continues To Push Forward With Multiple Positive CNS Studies

Sage Therapeutics Continues To Push Forward With Multiple Positive CNS Studies.....»»

Category: topSource: seekingalphaJan 8th, 2019

Acer Therapeutics enters into license agreement with Sanofi for osanetant

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 2nd, 2019

Acer Therapeutics submits Edsivo NDA to FDA, granted priority review

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 26th, 2018

Acer Therapeutics initiated with a Buy at Needham

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 20th, 2018

Amicus Therapeutics: Multiple Value Drivers In Play

Amicus Therapeutics: Multiple Value Drivers In Play.....»»

Category: topSource: seekingalphaDec 19th, 2018

Acer Therapeutics appoints Salma Jutt as CCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 17th, 2018

Sorrento Therapeutics has multiple catalysts in 2019, says H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2018

Aldeyra Therapeutics: Multiple Readouts Ahead In 2019

Aldeyra Therapeutics: Multiple Readouts Ahead In 2019.....»»

Category: topSource: seekingalphaDec 5th, 2018

Hedge Fund and Insider Trading News: Crispin Odey, Paulson & Co., Point72 Asset Management, Acer Therapeutics Inc (ACER), Contango Oil & Gas (MCF), and More

Steve Cohen’s Point72 Is Exploring Raising Venture Fund (Bloomberg) Steve Cohen’s Point72 Asset Management has discussed with clients the .....»»

Category: topSource: insidermonkeyNov 29th, 2018

Acer Therapeutics: Celiprolol Is Promising, But Acer Could Have Done A Proper Trial

Acer Therapeutics: Celiprolol Is Promising, But Acer Could Have Done A Proper Trial.....»»

Category: topSource: seekingalphaNov 19th, 2018

Acer Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Acer continues to progress towards goal of commercializing EDSIVO™ Company appoints VPs of Corporate Development and IT & Database Administrator NEWTON, Mass., Nov. 09, 2018 (GLOBE .....»»

Category: earningsSource: benzingaNov 9th, 2018

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination regimens in multiple cancer settings......»»

Category: blogSource: 247wallstNov 6th, 2018